BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25223258)

  • 21. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument.
    Palmer BW; Dunn LB; Appelbaum PS; Mudaliar S; Thal L; Henry R; Golshan S; Jeste DV
    Arch Gen Psychiatry; 2005 Jul; 62(7):726-33. PubMed ID: 15997013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Validation of the FINDRISC (FINnish Diabetes RIsk SCore) for prediction of the risk of type 2 diabetes in a population of southern Spain. Pizarra Study].
    Soriguer F; Valdés S; Tapia MJ; Esteva I; Ruiz de Adana MS; Almaraz MC; Morcillo S; García Fuentes E; Rodríguez F; Rojo-Martinez G
    Med Clin (Barc); 2012 Apr; 138(9):371-6. PubMed ID: 21939990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 2 diabetes mellitus in people with severe mental illness: inequalities by ethnicity and age. Cross-sectional analysis of 588 408 records from the UK.
    Das-Munshi J; Ashworth M; Dewey ME; Gaughran F; Hull S; Morgan C; Nazroo J; Petersen I; Schofield P; Stewart R; Thornicroft G; Prince MJ
    Diabet Med; 2017 Jul; 34(7):916-924. PubMed ID: 27973692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Feasibility and benefit of an active screening for rehab need and subsequent written advice to file an application for rehab treatment in AOK-insurants enrolled in the disease management program diabetes type 2 (PARTID-trial)].
    Mittag O; Döbler A; Pollmann H; Farin-Glattacker E; Raspe H
    Rehabilitation (Stuttg); 2014 Oct; 53(5):313-20. PubMed ID: 25317897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving diabetes care among patients with severe mental illness: A systematic review of the effect of interventions.
    Grøn AO; Dalsgaard EM; Ribe AR; Seidu S; Mora G; Cebrián-Cuenca AM; Charles M
    Prim Care Diabetes; 2018 Aug; 12(4):289-304. PubMed ID: 29709403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Japanese Metabolic Syndrome Risk Score (JAMRISC): a newly developed questionnaire used as a screening tool for diagnosing metabolic syndrome and insulin resistance in Japan.
    Tan C; Sasagawa Y; Kamo KI; Kukitsu T; Noda S; Ishikawa K; Yamauchi N; Saikawa T; Noro T; Nakamura H; Takahashi F; Sata F; Tada M; Kokai Y
    Environ Health Prev Med; 2016 Nov; 21(6):470-479. PubMed ID: 27699688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validating the CANRISK prognostic model for assessing diabetes risk in Canada's multi-ethnic population.
    Robinson CA; Agarwal G; Nerenberg K
    Chronic Dis Inj Can; 2011 Dec; 32(1):19-31. PubMed ID: 22153173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
    Salinero-Fort MA; Burgos-Lunar C; Lahoz C; Mostaza JM; Abánades-Herranz JC; Laguna-Cuesta F; Estirado-de Cabo E; García-Iglesias F; González-Alegre T; Fernández-Puntero B; Montesano-Sánchez L; Vicent-López D; Cornejo-Del Río V; Fernández-García PJ; Sánchez-Arroyo V; Sabín-Rodríguez C; López-López S; Patrón-Barandio P; Gómez-Campelo P;
    PLoS One; 2016; 11(7):e0158489. PubMed ID: 27441722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Congruence between the Indian Diabetes Risk Score and Australian Type 2 Diabetes Risk Assessment tool screening in Asian-Indians.
    Fernandez RS; Frost S
    Nurse Res; 2013 Nov; 21(2):36-9. PubMed ID: 24171636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. General health and quality-of-life measures in active, recent, and comorbid mental disorders: a population-based health 2000 study.
    Pirkola S; Saarni S; Suvisaari J; Elovainio M; Partonen T; Aalto AM; Honkonen T; Perälä J; Lönnqvist J
    Compr Psychiatry; 2009; 50(2):108-14. PubMed ID: 19216886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Process evaluation of a stepped-care program to prevent depression in primary care: patients' and practice nurses' experiences.
    Pols AD; Schipper K; Overkamp D; van Dijk SE; Bosmans JE; van Marwijk HW; Adriaanse MC; van Tulder MW
    BMC Fam Pract; 2017 Feb; 18(1):26. PubMed ID: 28231847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The EUCCLID study: proposed European study on care and complications in people with type 2 diabetes in primary care.
    Bobbink IW; Gorter KJ; Rutten GE; Wens J; Claramunt XC; Topsever P; Khunti K;
    Prim Care Diabetes; 2007 Sep; 1(3):167-71. PubMed ID: 18632039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000.
    Rathmann W; Martin S; Haastert B; Icks A; Holle R; Löwel H; Giani G;
    Arch Intern Med; 2005 Feb; 165(4):436-41. PubMed ID: 15738374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of a stepped-care intervention to prevent major depression in patients with type 2 diabetes mellitus and/or coronary heart disease and subthreshold depression: A pragmatic cluster randomized controlled trial.
    Pols AD; van Dijk SE; Bosmans JE; Hoekstra T; van Marwijk HWJ; van Tulder MW; Adriaanse MC
    PLoS One; 2017; 12(8):e0181023. PubMed ID: 28763451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translation and validation of the Canadian diabetes risk assessment questionnaire in China.
    Guo J; Shi Z; Chen JL; Dixon JK; Wiley J; Parry M
    Public Health Nurs; 2018 Jan; 35(1):18-28. PubMed ID: 29285800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic factors in patients with non-ST-segment elevation acute coronary syndrome concurrent with type 2 diabetes mellitus (according to the results of the registry)].
    Golikov AP; Berns SA; Stryuk RI; Shmidt EA; Golikova AA; Barbarash OL
    Ter Arkh; 2017; 89(3):65-71. PubMed ID: 28378733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychometric and screening properties of the WHO-5 well-being index in adult outpatients with Type 1 or Type 2 diabetes mellitus.
    Hajos TR; Pouwer F; Skovlund SE; Den Oudsten BL; Geelhoed-Duijvestijn PH; Tack CJ; Snoek FJ
    Diabet Med; 2013 Feb; 30(2):e63-9. PubMed ID: 23072401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The relationship between polipharmacy, chronic complications and depression in individuals with type 2 diabetes mellitus].
    do Nascimento AB; Chaves EC; Grossi SA; Lottenberg SA
    Rev Esc Enferm USP; 2010 Mar; 44(1):40-6. PubMed ID: 20394217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is newly diagnosed type 2 diabetes treated according to the guidelines? Results of the Polish ARETAEUS1 study.
    Bała MM; Płaczkiewicz-Jankowska E; Topór-Mądry R; Leśniak W; Jaeschke R; Sieradzki J; Grzeszczak W; Banasiak W;
    Pol Arch Med Wewn; 2011; 121(1-2):7-17. PubMed ID: 21346692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associated Risk Factors for Latent Tuberculosis Infection in Subjects with Diabetes.
    Martínez-Aguilar G; Serrano CJ; Castañeda-Delgado JE; Macías-Segura N; Hernández-Delgadillo N; Enciso-Moreno L; García de Lira Y; Valenzuela-Méndez E; Gándara-Jasso B; Correa-Chacón J; Bastián-Hernández Y; Rodríguez-Morán M; Guerrero-Romero F; Enciso-Moreno JA
    Arch Med Res; 2015 Apr; 46(3):221-7. PubMed ID: 25864989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.